This article (1) has been retracted at the request of the editors. Following an institutional review, it was determined that the same image was used to represent zerumbone (day 0) and zerumbone (after day 3) in Fig. 4A. In addition, a second image from a previously published article (2) was used to represent zerumbone (after day 1) in Fig. 4A. The original research records related to the figures were not available during the review. Therefore, the institution was not able to determine which of the published images were correct.

A copy of this Retraction Notice was sent to the last known e-mail addresses for all four authors. One author (B.O. Oyajobi) agreed to the retraction; two authors (B. Sung and B.B. Aggarwal) did not agree to the retraction; the remaining author (A. Murakami) did not respond.

1.
Sung
B
,
Murakami
A
,
Oyajobi
BO
,
Aggarwal
BB
. 
Zerumbone abolishes RANKL-induced NF-κB activation, inhibits osteoclastogenesis, and suppresses human breast cancer–induced bone loss in athymic nude mice
.
Cancer Res
2009
;
69
:
1477
84
.
2.
Ichikawa
H
,
Aggarwal
BB
. 
Guggulsterone inhibits osteoclastogenesis induced by receptor activator of nuclear factor-κB ligand and by tumor cells by suppressing nuclear factor-κB activation
.
Clin Cancer Res
2006
;
12
:
662
8
.